BillionToOne, Inc. IPO Research Information

BillionToOne, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on BillionToOne, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
BillionToOne, Inc.	BLLN - NASDAQ	$49.00-$55.00	$60.00	$100.00	4.55 million	11/6/2025
Underwriter(s): J.P. Morgan, Piper Sandler, Jefferies, William Blair, Stifel, Wells Fargo Securities, BTIG
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2025-10-07 Terms Added 2025-10-17

BillionToOne, Inc. Quote & Chart - Click for current quote - BLLN

About BillionToOne, Inc. (adapted from BillionToOne, Inc. prospectus):
BillionToOne is a precision diagnostics company using molecular technology to detect disease “one molecule at a time.” The company offers genetic testing solutions that empower patients with actionable health insights.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "BLLN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.